STAT+: With $173 million, new startup takes aim at sickle cell
Researchers are seeking a sickle cell treatment as effective as gene therapy, without the drawbacks. This entrepreneur thinks he might have one.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.